Announced Mon, 13 Jul · 18:43 IST

Intimation of shifting of Registered Office of the Company within the local limits of city of Mumbai.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹1100.00
prior close
₹1113.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-1.1+1.8-1.1-0.8-2.8
Up moveDown movePending
AI summary

Jenburkt Pharmaceuticals has informed BSE that its Board, via a circular resolution dated 13th July 2026, approved shifting the company's registered office within Mumbai. The new address will be the 14th floor, Unicorn, Dattaji Salvi Marg, off Veera Desai Road, Andheri West, Mumbai 400 053, effective 21st July 2026. The office is moving from Nirmala Apartments, Jay Prakash Road, Andheri West (old pincode 400 058) — both old and new locations are in Andheri West. There is no change in the Registrar of Companies (ROC) jurisdiction, telephone number, email, or website. This is a routine administrative disclosure made under SEBI Listing Regulation 30.

Likely market impact

This is a purely administrative relocation within the same area of Mumbai with no change in operations, contact details, or regulatory jurisdiction. Shareholders and customers do not need to take any action, and there is no expected impact on the stock price or business.